The role of endogenous ancestral nucleotide sequences in health and disease

Viruses have been suspected of contributing to the development of neurodegenerative diseases such as Parkinson’s, Alzheimer’s, multiple sclerosis and dementia. Their interaction with specific regions of the genome has shown to result in disease activation. These viruses shift the paradigm as they are not external invaders, but rather a natural part of our genetic makeup, passed down over generations known as endogenous ancestral nucleotide sequences (EANS).

This has ignited FBB Biomed’s focus towards an RNA sequencing-machine learning approach to monitor the activation of EANS in individuals with specific neurodegenerative diseases. This breakthrough allows for high level diagnostic precision in support of targeted treatment development strategies.

Join Dr. Howard Urnovitz, CEO of FBB Biomed, as he discusses hot topics including artificial intelligence (AI), emerging research of virology behaviors and the therapeutic challenges faced in viral-genomic interaction. FBB Biomed’s aim is to allow researchers to focus on disease specific areas of DNA, to shed light on targets for pharmaceutical progression.

Key learning objectives

  • Explore the role of viral-genomic interactions in health and disease
  • Understand the concept that viruses interact with the host genome, rather than acting in isolation
  • Explore emerging research and its implications for understanding viral behavior and treatment strategies

Who should attend?

Public health administrators, molecular biologists, virologists, and medical researchers

Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

Please find further information on LGC's Molecular Diagnostics equipment here.

Speakers

Dr. Howard Urnovitz
Dr. Howard Urnovitz
CEO, FBB Biomed, Inc.

Dr. Howard Urnovitz, CEO of FBB Biomed, has over 40 years of experience in the biotechnology industry. His expertise spans across RNA virology, genomics, artificial intelligence (AI), and chronic diseases. He earned his Ph.D. in Microbiology and Immunology from the University of Michigan and completed postdoctoral work in tumor immunology at Washington University and the University of Iowa. His outstanding background led to him producing the first liquid biopsy technique as well as developing a HIV urine confirmation test.

Moderator

Olivia Long
Olivia Long
Editorial Team, SelectScience

Links

Tags